Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by HerrMasashion Dec 06, 2018 10:15am
75 Views
Post# 29075184

RE:GENIUS SHORTERS WENT TO WRONG ADDRESS

RE:GENIUS SHORTERS WENT TO WRONG ADDRESSbut there was a disclaimer, that it should not be intended as investment advice, yet people bought into the fear and took it as investment advice. 

why couldnt a multimillion dollar fund, looking for the best interest of investors just fly out to jamaica quickly for a weekend and confirm the address after they got word of it 2 months ago?? 

it's much easier to distort the truth from the uneducated investors that are in cannabis. :) 

canucks444 wrote: Got all my shares for sale at $100. Shorters cant use them. Aphria is legit. Everything was done legit with full transparency. Only a matter of time till Aphria is cleared of these trumped up amateur allegations. In the mean time I'm buying. Good luck.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities